Answers are grounded in this paper and cite their sources.
BACKGROUND: Melanoma incidence continues to rise in England, but inequities in cancer outcomes persist despite universal healthcare. Socioeconomic deprivation has been linked to poorer outcomes across several cancer types, yet comprehensive national data on its impact in melanoma are limited. OBJECTIVES: To examine the influence of socioeconomic status upon malignant melanoma incidence, stage at diagnosis, treatment and outcomes in England. METHODS: This population-based cohort study included 68,869 patients diagnosed with malignant melanoma in England between 2016 and 2020, identified from the National Disease Registration Service and linked to Hospital Episode Statistics, mortality data and the Systemic Anti-Cancer Therapy (SACT) dataset. Logistic regression examined associations between deprivation (Index of Multiple Deprivation quintiles) and stage at presentation, treatment received and mortality, adjusting for demographic and clinical covariates. RESULTS: Compared with patients in the least deprived quintile, those in the most deprived quintile were diagnosed at a younger median age (62 vs 67 years) and more often with stage 4b disease (10% vs 8%). After adjustment, patients in the least deprived quintile were more likely than those in the most deprived quintile to receive systemic therapies (aOR 1.13, 95% CI 1.02-1.25, p = 0.02) and less likely to die from any cause within one year (aOR 0.71, 95% CI 0.62-0.82, p < 0.001). CONCLUSIONS: In England, living in a more deprived area is modestly associated with more advanced melanoma at diagnosis, lower receipt of systemic therapy and higher one-year mortality. Melanoma awareness, early detection and access to systemic therapy should be targeted towards patients living in the most deprived areas.
No takes yet. Share an insight, caveat, or question.
Boyle et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: